ICA-17043

DRUG2 trials

Sponsors

Icagen

Conditions

Sickle Cell AnemiaSickle Cell Disease

Phase 3

A Stratified Sickle Event Randomized Trial (ASSERT)

TerminatedNCT00102791

IcagenSickle Cell Disease

Start: 2005-02-28End: 2007-06-30Updated: 2008-03-27

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

TerminatedNCT00294541

IcagenSickle Cell Anemia, Sickle Cell Disease

Start: 2006-02-28End: 2007-06-30Updated: 2007-09-11